论文部分内容阅读
载脂蛋白 B(Apo B)是低密度脂蛋白的主要载脂蛋白,调节体内胆固醇合成。本文报告81例慢性肝病患者血清 Apo B 含量,以探讨 ApoB 含量与慢性肝病之间的关系。对象和方法一、临床资料(一)正常对照组:74例,男40例,女34例。系本院健康献血员和健康查体者。(二)观察组:肝硬化60例,慢性肝炎21例,临床诊断符合1984年南宁肝炎会议标准。
Apolipoprotein B (Apo B) is the major apolipoprotein of low density lipoproteins and regulates cholesterol synthesis in the body. This article reports 81 cases of chronic liver disease in patients with serum Apo B levels to explore the relationship between ApoB content and chronic liver disease. Subjects and methods First, the clinical data (a) normal control group: 74 cases, 40 males and 34 females. Department of Health blood donors and health examination who. (B) the observation group: cirrhosis in 60 cases, 21 cases of chronic hepatitis, clinical diagnosis consistent with the 1984 Nanning hepatitis meeting standards.